This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Brajendra Kumar Tripathi: Innovator in Antihyperglycemic Research
Introduction
Brajendra Kumar Tripathi is a notable inventor based in Lucknow, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for managing diabetes and related conditions. His work focuses on creating effective solutions for health issues that affect millions worldwide.
Latest Patents
One of his key patents is titled "Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents." This invention provides novel substituted flavone derivatives that exhibit anti-hyperglycemic and antidyslipidemic activity. The patent outlines a method for controlling type II diabetes and associated hyperlipidemic conditions in mammals by administering compounds derived from these innovative derivatives. He holds 1 patent in this area.
Career Highlights
Brajendra Kumar Tripathi is affiliated with the Council of Scientific and Industrial Research, where he conducts research aimed at improving public health through innovative solutions. His work has garnered attention for its potential impact on diabetes management, a growing concern in today's society.
Collaborations
He has collaborated with several esteemed colleagues, including Ram Pratap and Mavurapu Satyanarayana, to further advance research in his field. Their combined expertise contributes to the development of effective therapeutic agents.
Conclusion
Brajendra Kumar Tripathi's contributions to the field of medicinal chemistry, particularly through his innovative patent on antihyperglycemic agents, highlight his commitment to improving health outcomes. His work exemplifies the vital role of inventors in addressing pressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
